Takeda’s dengue shot keeps 84% of kids out of hospital regardless of prior infection, giving it a leg up over Sanofi's Dengvaxia
With filings under way in Europe, Brazil, and a trio of Southeast Asian nations, Takeda unveiled long-term data for its dengue vaccine, showing the shot’s efficacy waned over time but that it was st...